NASDAQ •
Technology •
Computer Hardware •
Quote as of 09/16/2026 16:00
Company Profile
IndustryComputer Hardware
SectorTechnology
ExchangeNASDAQ
Market Capitalization17.69 mln
Float1.79 mln
Earnings Date11/19/2026
Piotroski F-Score
3
/ 9
Below average
Relative Strength
0
/ 100
Severely lagging
Debt / Equity
0.02
Debt-free
ROE
-106
Deeply negative
ROA
-52.85
Deeply negative
Business Description
Q/C Technologies Inc. is a clinical-stage pharmaceutical company founded in 2014 and based in New York, working to develop new treatments for a range of serious conditions, including autoimmune diseases, epilepsy, pain, and anxiety. Its two lead drug candidates are Isomyosamine, which targets the body's immune and metabolic systems, and Supera-CBD, a lab-made compound derived from cannabidiol. Beyond pharmaceuticals, the company is also building computing technology designed to support artificial intelligence applications. Formerly known as TNF Pharmaceuticals Inc., Q/C Technologies maintains a research partnership with the DADA2 Foundation to study a rare inflammatory disease called DADA2.
